Company / Free Cash Flow per Share
Eton Pharmaceuticals, Inc. Free Cash Flow per Share History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Free Cash Flow per Share
$0.27
FY2025
5-year range
-$0.91 / $0.27
FY2021-FY2025
Trend
+40.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Free Cash Flow per Share has increased for 3 consecutive years, from $-0.91 in FY2022 to $0.27 in FY2025.
Based on SEC 10-K filings.
0.27 in FY2025.
Improved from $-0.19 to $0.27 over the past 2 years.
Free Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- Eton Pharmaceuticals, Inc.'s free cash flow per share has grown for 3 consecutive years.
- In FY2025, free cash flow per share increased 40.6% year-over-year.
- Lowest free cash flow per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score 0.63 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Free Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.27 | +40.6% |
| FY2024 | $0.19 | +197.0% |
| FY2023 | -$0.19 | +78.6% |
| FY2022 | -$0.91 | -15.6% |
| FY2021 | -$0.79 | -67.8% |
| FY2020 | -$0.47 | -70.3% |
| FY2019 | -$0.28 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026